INTERNATIONAL PATENT: NACUITY PHARMACEUTICALS, INC. FILES APPLICATION FOR "N-ACETYLCYSTEINE AMIDE INHIBITS REDUCTION IN VISION IN PATIENTS WITH USHER SYNDROME ASSOCIATED RETINITIS PIGMENTOSA"

GENEVA, April 8 -- NACUITY PHARMACEUTICALS, INC. (306 W. 7th Street, Suite 310Fort Worth Club BuildingFort Worth, TX 76102) filed a patent application (PCT/US2025/047745) for "N-ACETYLCYSTEINE AMIDE INHIBITS REDUCTION IN VISION IN PATIENTS WITH USHER SYNDROME ASSOCIATED RETINITIS PIGMENTOSA" on Sep 24, 2025. With publication no. WO/2026/072694, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WALL, G., Michael (4405 Overton Crest StreetFort Worth, TX 76109), KERN, Jami (4009 Monticello DriveFort Worth, TX 76107)

Abstract:...